Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial (vol 19, pg 1001, 2019)

Mullane K. M.; Morrison V. A.; Camacho L. H.

首页> 外文期刊>The Lancet infectious diseases >Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial (vol 19, pg 1001, 2019)

【24h】

Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial (vol 19, pg 1001, 2019)

机译：灭活的水痘带状疱疹病毒疫苗在免疫功能性的恶性肿瘤患者中的安全性和有效性：双臂，随机，双盲，第3阶段试验（Vol 19，PG 1001,2019）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Lancet infectious diseases》 |2019年第10期|共1页
作者
Mullane K. M.; Morrison V. A.; Camacho L. H.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类传染病;
关键词

相似文献

外文文献
中文文献
专利

1. Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial (vol 19, pg 1001, 2019) [J] . Mullane K. M., Morrison V. A., Camacho L. H. The Lancet infectious diseases . 2019,第10期

机译：灭活的水痘带状疱疹病毒疫苗在免疫功能性的恶性肿瘤患者中的安全性和有效性：双臂，随机，双盲，第3阶段试验（Vol 19，PG 1001,2019）
2. Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised clinical trials and post-hoc efficacy analysis (vol 19, pg 988, 2019) [J] . Dagnew A. F., Ilhan A., Lee W-S The Lancet infectious diseases . 2020,第1期

机译：具有血液恶性肿瘤的成人中佐剂重组带状疫苗的免疫原性和安全性：第3期，随机临床试验和HOC后疗效分析（Vol 19，PG 988,2019）
3. Safety and Immunogenicity of Inactivated Varicella-Zoster Virus Vaccine in Adults With Autoimmune Disease: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial [J] . MichaelEberhardson, StephenHall, Kim APapp, Clinical infectious diseases . 2017,第7期

机译：具有自身免疫疾病的成人中的灭活水痘 - 带状疱疹病毒疫苗的安全性和免疫原性：A相，随机，双盲，安慰剂控制的临床试验
4. AFIELD TRIAL TO ASSESS THE EFFICACY OF AN INACTIVATED SUBUNIT VACCINE (PORCILIS ~R PCV) AGAINST PORCINE CIRCOVIRUS TYPE 2 (PCV2) IN A CANADIAN PIG HERD WITH PCV2-ASSOCIATED DISEASE [C] . Alberto Ruiz, Robert Friendship, Zvonimir Poljak, Congress ofthe International Pig Veterinary Society . 2008

机译：通过PCV2相关疾病评估灭活亚基疫苗（Porcilis〜R PCV）对加拿大猪群中的猪胃肠病毒2（PCV2）的疗效的疗效
5. A randomized double-blind placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated Vero cell): a structured summary of a study protocol for a randomised controlled trial [O] . Murat Akova, Serhat Unal 2021

机译：随机双盲安慰剂对照期III临床试验评价SARS-COV-2疫苗（灭活VERO细胞）的功效和安全性：随机对照试验的研究方案的结构性概述
6. Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial [O] . Kathryn E Stephenson, Chen Sabrina Tan, Stephen R Walsh, 2020

机译：Zika纯化的灭活病毒疫苗的安全性和免疫原性通过标准，加速或缩短的时间表：单中心，双盲，顺序组，随机化，安慰剂控制，第1阶段试验

Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial (vol 19, pg 1001, 2019)

著录项

相似文献

相关主题

期刊订阅